Skip to main content

Table 2 Multivariate logistic regression analysis of factors associated with death in UFES patients

From: Remdesivir administration for SARS-CoV-2 pneumonia in ICU and non-ICU patients: outcome and posttreatment differences — the Italian Military Hospital experience

Death

OR (95% CI)

p

Treatment with remdesivir

0.10 (0.04–0.30)

 < 0.001*

Comorbidities (2 or more)

13.58 (1.68–109.95)

0.014*

Sex (male)

1.89 (0.73–4.92)

0.190

Age (> 60 years)

20.4 (2.53–164.41)

 < 0.005*

  1. *Statistical significance (p < 0.05)